Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03918135Phase 4Completed
Phase 4, randomised, double-blind trial in fever comparing Paracetamol with Ibuprofen (2 arms). Primary endpoint: Decreasing of fever at 120 months. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03918135.